What Zai Lab Ltd does.

We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States. We are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. We intend to leverage our competencies and resources to positively impact human health. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies to generate a broad pipeline, including multiple commercial products and multiple programs in late-stage clinical development. We have also built an in-house R&D team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights.

Our mission is to be a leading global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies that improve the lives of patients. To execute on that mission, we have developed a corporate strategy with the following three pillars to help us drive innovation:

• Accelerate Medicines to Patients: We seek to advance our global and regional pipelines by continuing to invest in research and development activities;

Revenue and profit, by fiscal year.

More on ZLAB.

• Zai Lab Ltd summary
• Zai Lab Ltd financial statements
• Zai Lab Ltd key metrics
• Zai Lab Ltd health scores and style box
• Zai Lab Ltd earnings
• Zai Lab Ltd dividends
• Zai Lab Ltd valuation
• Zai Lab Ltd ownership and insiders
• Zai Lab Ltd peers

Figures from Zai Lab Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.